Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Zabedosertib and Interaction with Methotrexate
NCT03244462Phase 1Completed
- Sponsor
- Bayer
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zabedosertib in Inflammatory Disorders (4 arms), sponsored by Bayer. Primary endpoints: Area under the concentration-versus-time curve, Maximum concentration attained and 5 more. Started Aug 2017; status: completed.
02
Drugs
zabedosertib
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NCT03244462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03244462.